After six years of existence and raising more than $20 million, Personal Genome Diagnostics has its first full-time CEO.
Douglas Ward will head the Canton-based Johns Hopkins spinout and sit on its board, the company announced Monday.
{iframe}http://technical.ly/baltimore/2016/05/10/personal-genome-diagnostics-ceo-douglas-ward/?utm_source=Technically+Media&utm_campaign=2732ea142e-BaltimoreDailyNewsletter&utm_medium=email&utm_term=0_dde0db1108-2732ea142e-408421769{/iframe}